Literature DB >> 11275714

Management and aetiology of stones in intestinal urinary reservoirs in adolescents.

C R Woodhouse1, G N Lennon.   

Abstract

OBJECTIVE: To review the aetiology and management of reservoir stones in patients with intestinal urinary reservoirs. SUBJECTS AND METHODS: Since 1983 patients with enterocystoplasty have been followed prospectively by protocol. The data sets and notes of 148 patients reconstructed for congenital anomalies were reviewed to retrieve information on the incidence, management and aetiology of reservoir stones.
RESULTS: Data were complete on 146 patients, 2 others having been lost to follow-up. Mean follow-up was 3.4 (range 1-14) years. Twenty-three patients formed stones (15.8%). Mean time to stone formation was 45 months (range 1 month to 10 years). In 13 patients the stones were removed by a percutaneous approach. In 9 patients with large stones (>5 cm) an open removal was performed. One patient had a small stone removed through a Kock nipple. All stones were struvite on analysis. All patients with an augmented bladder drained by a supra-pubic Mitrofanoff formed stones at some time. The incidence of stones in other groups was: Kock pouch 50%; reservoirs drained by urethral catheterisation 9%; all other abdominal reservoirs 7.5%. No patient who voided spontaneously formed stones.
CONCLUSION: Reservoir stones are infective in composition. The incidence is strongly related to the lack of downward, gravitational emptying. Stones up to 5 cm can be removed percutaneously.

Entities:  

Mesh:

Year:  2001        PMID: 11275714     DOI: 10.1159/000052448

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  2 in total

1.  Metabolic factors in the causation of urinary tract stones in patients with enterocystoplasties.

Authors:  W G Robertson; C R J Woodhouse
Journal:  Urol Res       Date:  2006-03-08

2.  Urolithiasis in adult spina bifida patients: study in 260 patients and discussion of the literature.

Authors:  Paul W Veenboer; J L H Ruud Bosch; Floris W A van Asbeck; Laetitia M O de Kort
Journal:  Int Urol Nephrol       Date:  2013-04-19       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.